|
End-of-day quote
Nasdaq
13/11/2026
|
5-day change | 1st Jan Change | ||
| 8.480 USD | +0.24% |
|
+0.36% | -42.51% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
65f.4oXKArRlQnDR8NOH2JoUDxnZLX-rcd9KYKYQ5aV7AZw.gMn9N4MxLEe5m-Twrv9VXVGxX0_lR-gpItVpoJY0ZPOPyI17zioaBb6qng~f3dea263ca1b60e7492f049d9506b098


Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.480USD
Average target price
20.00USD
Spread / Average Target
+135.85%
High Price Target
22.00USD
Spread / Highest target
+159.43%
Low Price Target
18.00USD
Spread / Lowest Target
+112.26%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
















